ABOUT US

EVOQ Therapeutics is a cancer immunotherapy company driven to improve the lives of cancer patients by unleashing the full potential of cancer vaccines

OUR TECHNOLOGY

We have demonstrated that

our proprietary technology

evokes potent anti-tumor

T-cell responses that can eradicate tumors and establish long-term immunity against

tumor recurrence in a variety of pre-clinical models

PUBLICATIONS

See these papers published

in peer-reviewed journals

for more information about

our technology and approach

to cancer immunotherapy